Free Trial
→ Watch This Robotics Demo Before July 23rd (From Brownstone Research) (Ad) Buy SBTX Stock  Free SBTX Stock Alerts

Silverback Therapeutics (SBTX) SEC Filings & 10K Form

Silverback Therapeutics logo
$14.98 +0.46 (+3.17%)
As of 05/23/2025
Compare

Recent Silverback Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
05/20/2025
4:24 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Scott Kathleen D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
3:48 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
SAUNDERS BRENT L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
3:50 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Fitzpatrick Alexander A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2025
6:01 AM		Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
6:03 AM		Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2025
7:05 AM		Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2025
3:45 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Shawver Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
1:26 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Shawver Laura (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/24/2025
6:57 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Flynn James E (Filed by)
Form SCHEDULE 13D/A
03/21/2025
5:30 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Karas Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:03 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Karas Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:05 PM		Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/20/2025
6:02 AM		Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2025
6:04 AM		Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2025
4:12 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Shawver Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
4:18 PM		Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
4:19 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Shawver Laura (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
3:35 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Shawver Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
11:06 AM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Shawver Laura (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
4:21 PM		Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form S-3ASR
01/13/2025
7:08 AM		Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
5:24 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Shawver Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:36 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Shawver Laura (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/19/2024
3:20 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
3:20 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
6:52 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Dorsey Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
6:53 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Chakma Justin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
4:24 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2024
4:41 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Chakma Justin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:02 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
5:30 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
5:30 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:31 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Dorsey Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
3:48 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
10:15 AM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Lowenthal Richard E (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/09/2024
4:43 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
4:25 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
11:38 AM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Shawver Laura (Reporting)
Form 144/A
12/06/2024
6:15 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Chakma Justin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
4:30 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/05/2024
4:06 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
A grave, grave error. (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.
12/03/2024
4:25 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
6:01 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
5:22 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Shawver Laura (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
3:42 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Karas Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
3:11 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Chakma Justin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:30 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:30 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
2:21 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2024
7:16 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt III, L.P. (Reporting)
Deerfield Mgmt IV, L.P. (Reporting)
Deerfield Private Design Fund III, L.P. (Reporting)
Deerfield Private Design Fund IV, L.P. (Reporting)
Flynn James E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
6:02 AM		Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
6:00 AM		Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
3:30 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2024
3:30 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2024
3:30 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Scott Kathleen D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
3:01 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Scott Kathleen D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
10:28 AM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Tanimoto Sarina (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
6:02 AM		Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
3:27 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2024
3:28 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
3:15 PM		Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:26 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:29 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:30 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Karas Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:06 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Karas Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:24 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:25 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
9:31 AM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Lowenthal Richard E (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
3:30 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
5:41 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
5:38 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
ORBIMED CAPITAL LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:43 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
ORBIMED CAPITAL LLC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2024
5:47 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:48 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:49 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Scott Kathleen D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:51 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Karas Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:51 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Dorsey Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:18 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Scott Kathleen D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2024
3:30 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:30 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:30 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Dorsey Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
6:59 AM		Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
3:30 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
3:30 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
11:07 AM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Tanimoto Sarina (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/11/2024
4:03 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
4:04 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
2:15 PM		Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
5:46 AM		Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2024
4:06 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Dadoo Rajeev (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
4:13 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
White House to reset Social Security? (Ad)

Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.

And it could have a major impact on how you collect Social Security - Click here to understand what'
06/21/2024
4:00 PM		Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
7:47 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Pratik Shah Living Trust dated June 15, 2011 (Filed by)
Form SC 13D/A
06/17/2024
5:39 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Shah Pratik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:30 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:18 PM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Pratik Shah Living Trust dated June 15, 2011 (Filed by)
Form SC 13D/A
06/11/2024
10:36 AM		Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Lowenthal Richard E (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2024
8:09 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Pratik Shah Living Trust dated June 15, 2011 (Reporting)
Shah Pratik (Reporting)
Form 4/A
06/07/2024
8:11 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Shah Pratik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:32 PM		Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Pratik Shah Living Trust dated June 15, 2011 (Reporting)
Shah Pratik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SBTX) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...
Colonial Metals | Sponsored
Trump’s Bitcoin Reserve is No Accident…
Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...
Crypto 101 Media | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored